Triumpharma Inc. is a pioneer in developing systems and solutions for advanced drug delivery. We strive to bridge the gap between life science and modern healthcare.

Triumpharma Inc. develops technologies that enhance the performance of many of today's commonly available pharmaceutical products and new chemical entities that give raise to challenging bioavailability problems.

Triumpharma has strong technical capabilities to take products from feasibility to pilot scale. Triumpharma conducts formulation optimization studies, pre-clinical trials on animals, human clinical studies including bioavailability/ bioequivalence trial complying with the international guidelines. The company's core advantages are its extremely low-cost base, experienced staff with multi national experience, holding PhDs from western universities, high-quality research, a large pool of patient’s and volunteers, and fast formulation development meeting the necessary regulatory requirements.

Triumpharma key advantages

  1. Our Clinical Trial facilities (4 independent units has over 200 bed capacity. The independent units provide the flexibility to conduct different studies at the same time. The size of bed can be increased further with the present building or an adjacent building can be constructed.
  2. Our Familiarity with the International Reference and PK labs (shipment via world Courier)
  3. Our ability to recruit patients and healthy volunteers (large pool of patients and volunteers)
  4. Our Pharmacy Department which meets the Regulatory Requirements pertaining to IPs storage and dispensing space as well as continuous control and monitoring of temperature and humidity to maintain the integrity of the IPs.
  5. Specialized expertise such as LTA capabilities, familiarity with IVRS/IWRS, continuous vital signs monitoring, biomarkers analysis, trained staff on EDC and Medline systems, management software, and ongoing implementation of the latest LIMS, Randomization Software, 7195, ERPs, etc.
  6. Our experience >200 clinical trials over the last 5 years working with clients worldwide in three continents.
  7. Our competitive cost base.
  8. Our ability to complete studies to challenging deadlines.

This publication has been produced with the assistance of the European Union in cooperation with Jordan Enterprise Development Corporation. *

* The contents of this publication are the sole responsibility of Triumpharma and can in no way betaken to reflect the views of the European Union & Jordan Enterprise Development Corporation